Patents by Inventor James H. Meade

James H. Meade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11986179
    Abstract: Devices and methods for minimally invasive suturing are disclosed. One suturing device for minimally invasive suturing includes a proximal section a distal end, and an intermediate region therebetween. The device includes a suture head assembly having a suturing needle with a pointed end and a second end. The suturing needle is capable of rotating about an axis approximately perpendicular to a longitudinal axis of the device, wherein the pointed end of the suturing needle is positioned within the suture head assembly prior to deployment of guides that are adapted and configured to guide the needle around a circular path when advanced by a drive mechanism having a needle driver for engaging and rotating the suturing needle.
    Type: Grant
    Filed: November 22, 2020
    Date of Patent: May 21, 2024
    Assignee: Intuitive Surgical Operations, Inc.
    Inventors: Gerald I. Brecher, John C. Meade, John Aho, Roger Baske, James H. Bleck, John F Carlson, Thomas Eagan, Michael J. Helander, James W. Murray, Ashley Perkins, Wayne A. Shakal, Jonathan Towle
  • Patent number: 5268274
    Abstract: Nucleic acid sequences encoding the bacterial cellulose synthase operon derived from Acetobacter are disclosed. Methods for isolating the genes, vectors containing the genes, and transformed hosts useful for the expression of recombinant bacterial cellulose synthase or production of cellulose are also described.
    Type: Grant
    Filed: April 22, 1991
    Date of Patent: December 7, 1993
    Assignee: Cetus Corporation
    Inventors: Arie Ben-Bassat, Roger D. Calhoon, Anna L. Fear, David H. Gelfand, James H. Meade, Rony Tal, Hing Wong, Moshe Benziman
  • Patent number: 5045463
    Abstract: A gene having a DNA sequence complementary to that of the glucoamylase polypeptide mRNA from a fungal species, preferably Aspergillus awamori, is prepared. The mRNA is an approximately 2.2 kilobase poly A RNA obtained from fungal cells grown under conditions of glucoamylase induction. Reverse transcription of the mRNA provides a glucoamylase probe used to identify genomic digest fragments containing glucoamylase gene regions, which are sequenced to locate the introns and exons. The genomic fragments are spliced together to form a gene having a DNA sequence with altered or deleted introns which codes for fungal glucoamylase protein and is capable, when correctly combined with a cleaved DNA expression vector, of expressing a non-native protein having glucoamylase enzyme activity upon transformation of a host organism by the vector. The host is preferably bacteria or yeast. The transformed yeast host may be used to produce ethanol.
    Type: Grant
    Filed: December 19, 1988
    Date of Patent: September 3, 1991
    Assignee: Cetus Corporation
    Inventors: Michael A. Innis, David H. Gelfand, James H. Meade
  • Patent number: 4477571
    Abstract: Chimeric plasmids capable of transforming bacteria and yeast are described. The plasmids carry the Cm (chloramphenicol resistance) gene and the Tc (tetracycline resistance) gene as selectable markers. The Cm gene allows the plasmids to be selected for in wild-type strains of the yeast Saccharomyces cerevisiae. The Tc gene allows heterologous genes cloned into the plasmids to be selected for in Escherichia coli bacteria.
    Type: Grant
    Filed: February 5, 1982
    Date of Patent: October 16, 1984
    Assignee: Cetus Corporation
    Inventors: Shing Chang, James H. Meade